GALR2 and head and neck squamous cell carcinoma: In vivo, GALR2 induces invasion of HNSCC cells via NFATC2-mediated transcription of cyclooxygenase-2, which enzymatically facilitates prostaglandin E2 production, thereby promoting tumor progression [7].